Trans-Pacific Partnership Provisions in Intellectual Property, Transparency, and Investment Chapters Threaten Access to Medicines in the US and Elsewhere

Brook K Baker

doi:10.1371/journal.pmed.1001970

Trans-Pacific Partnership Provisions in Intellectual Property, Transparency, and Investment Chapters Threaten Access to Medicines in the US and Elsewhere

PLoS Med. 2016 Mar 8;13(3):e1001970. doi: 10.1371/journal.pmed.1001970. eCollection 2016 Mar.

Author

Brook K Baker^{1

2

3}

Affiliations

¹ Northeastern University School of Law, Program on Human Rights and the Global Economy, Boston, Massachusetts, United States of America.
² University of KwaZulu Natal, Durban, South Africa.
³ Health Global Access Project, New York, New York, United States of America.

Abstract

Brook Baker describes the potential harms to global health from the Trans Pacific Partnership Agreement and its failure to balance the interests of patients and the public with those of industry.

MeSH terms

Australia
Brunei
Canada
Chile
Drug Costs
Drug Industry / economics
Drug Industry / legislation & jurisprudence*
Drugs, Generic / economics
Drugs, Generic / supply & distribution*
Health Services Accessibility
Humans
Intellectual Property*
International Cooperation / legislation & jurisprudence*
Investments*
Japan
Malaysia
Mexico
New Zealand
Patents as Topic / legislation & jurisprudence
Peru
Pharmaceutical Preparations / economics
Pharmaceutical Preparations / supply & distribution
Singapore
United States
Vietnam

Substances

Drugs, Generic
Pharmaceutical Preparations

Grants and funding

No funding was received for this work.